Follow
Raymond Omollo
Raymond Omollo
Drugs for Neglected Diseases Initiative Africa
Verified email at dndi.org
Title
Cited by
Cited by
Year
Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial
A Musa, E Khalil, A Hailu, J Olobo, M Balasegaram, R Omollo, T Edwards, ...
PLoS neglected tropical diseases 6 (6), e1674, 2012
1762012
Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial
A Hailu, A Musa, M Wasunna, M Balasegaram, S Yifru, G Mengistu, ...
PLoS neglected tropical diseases 4 (10), e709, 2010
1552010
Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study
AM Musa, B Younis, A Fadlalla, C Royce, M Balasegaram, M Wasunna, ...
PLoS neglected tropical diseases 4 (10), e855, 2010
1202010
Prevalence of malaria parasites in adults and its determinants in malaria endemic area of Kisumu County, Kenya
R Jenkins, R Omollo, M Ongecha, P Sifuna, C Othieno, L Ongeri, ...
Malaria journal 14, 1-6, 2015
1172015
Efficacy and safety of AmBisome in combination with sodium stibogluconate or miltefosine and miltefosine monotherapy for African visceral leishmaniasis: phase II randomized trial
M Wasunna, S Njenga, M Balasegaram, N Alexander, R Omollo, ...
PLoS neglected tropical diseases 10 (9), e0004880, 2016
872016
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial
RO Phillips, J Robert, KM Abass, W Thompson, FS Sarfo, T Wilson, ...
The Lancet 395 (10232), 1259-1267, 2020
852020
Safety and efficacy of single dose versus multiple doses of AmBisome® for treatment of visceral leishmaniasis in eastern Africa: a randomised trial
EAG Khalil, T Weldegebreal, BM Younis, R Omollo, AM Musa, W Hailu, ...
PLoS neglected tropical diseases 8 (1), e2613, 2014
852014
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan …
BR Ogutu, KO Onyango, N Koskei, EK Omondi, JM Ongecha, GA Otieno, ...
Malaria journal 13, 1-10, 2014
742014
Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East …
R Omollo, N Alexander, T Edwards, EAG Khalil, BM Younis, AA Abuzaid, ...
Trials 12, 1-10, 2011
682011
Safety and effectiveness of sodium stibogluconate and paromomycin combination for the treatment of visceral leishmaniasis in eastern Africa: results from a pharmacovigilance …
R Kimutai, AM Musa, S Njoroge, R Omollo, F Alves, A Hailu, EAG Khalil, ...
Clinical drug investigation 37, 259-272, 2017
622017
A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia
E Diro, S Blesson, T Edwards, K Ritmeijer, H Fikre, H Admassu, A Kibret, ...
PLoS neglected tropical diseases 13 (1), e0006988, 2019
592019
Pharmacokinetics, safety, and efficacy of an allometric miltefosine regimen for the treatment of visceral leishmaniasis in Eastern African children: an open-label, phase II …
J Mbui, J Olobo, R Omollo, A Solomos, AE Kip, G Kirigi, P Sagaki, ...
Clinical Infectious Diseases 68 (9), 1530-1538, 2019
502019
Probable post traumatic stress disorder in Kenya and its associated risk factors: a cross-sectional household survey
R Jenkins, C Othieno, R Omollo, L Ongeri, P Sifuna, JK Mboroki, D Kiima, ...
International journal of environmental research and public health 12 (10 …, 2015
492015
Alcohol consumption and hazardous drinking in western Kenya—a household survey in a health and demographic surveillance site
R Jenkins, C Othieno, L Ongeri, D Kiima, P Sifuna, J Kingora, R Omollo, ...
BMC psychiatry 15, 1-10, 2015
452015
Common mental disorder in Nyanza province, Kenya in 2013 and its associated risk factors–an assessment of change since 2004, using a repeat household survey in a demographic …
R Jenkins, C Othieno, L Ongeri, P Sifuna, M Ongecha, J Kingora, D Kiima, ...
BMC psychiatry 15, 1-12, 2015
382015
Tedium vitae, death wishes, suicidal ideation and attempts in Kenya-prevalence and risk factors
R Jenkins, C Othieno, R Omollo, L Ongeri, P Sifuna, M Ongecha, ...
BMC Public Health 15, 1-11, 2015
332015
Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection
W Hailu, T Weldegebreal, Z Hurissa, H Tafes, R Omollo, S Yifru, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 104 (11 …, 2010
312010
Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort …
E Diro, T Edwards, K Ritmeijer, H Fikre, C Abongomera, A Kibret, ...
PLoS neglected tropical diseases 13 (2), e0007132, 2019
262019
Validation of two rapid diagnostic tests for visceral leishmaniasis in Kenya
J Mbui, M Wasunna, M Balasegaram, A Laussermayer, R Juma, ...
PLoS neglected tropical diseases 7 (9), e2441, 2013
182013
Single-dose liposomal amphotericin B (AmBisome®) for the treatment of Visceral Leishmaniasis in East Africa: study protocol for a randomized controlled trial
T Edwards, R Omollo, EAG Khalil, S Yifru, B Musa, A Musa, M Wasunna, ...
Trials 12, 1-7, 2011
162011
The system can't perform the operation now. Try again later.
Articles 1–20